Does RABEPRAZOLE Cause Agranulocytosis? 24 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 24 reports of Agranulocytosis have been filed in association with RABEPRAZOLE (Rabeprazole Sodium). This represents 0.2% of all adverse event reports for RABEPRAZOLE.
24
Reports of Agranulocytosis with RABEPRAZOLE
0.2%
of all RABEPRAZOLE reports
0
Deaths
18
Hospitalizations
How Dangerous Is Agranulocytosis From RABEPRAZOLE?
Of the 24 reports, 18 (75.0%) required hospitalization, and 1 (4.2%) were considered life-threatening.
Is Agranulocytosis Listed in the Official Label?
Yes, Agranulocytosis is listed as a known adverse reaction in the official FDA drug label for RABEPRAZOLE.
What Other Side Effects Does RABEPRAZOLE Cause?
Chronic kidney disease (4,773)
Renal failure (3,135)
Acute kidney injury (2,545)
End stage renal disease (1,295)
Tubulointerstitial nephritis (1,125)
Death (857)
Drug ineffective (732)
Dyspnoea (423)
Gastrooesophageal reflux disease (416)
Headache (387)
What Other Drugs Cause Agranulocytosis?
CLOZAPINE (1,766)
CYCLOPHOSPHAMIDE (1,242)
RITUXIMAB (1,154)
SULFAMETHOXAZOLE\TRIMETHOPRIM (797)
PANTOPRAZOLE (599)
METHOTREXATE (550)
SODIUM (549)
EPIRUBICIN (491)
METAMIZOLE (438)
DOCETAXEL (436)
Which RABEPRAZOLE Alternatives Have Lower Agranulocytosis Risk?
RABEPRAZOLE vs RACECADOTRIL
RABEPRAZOLE vs RADIATION THERAPY
RABEPRAZOLE vs RADIUM RA-223 DICHLORIDE
RABEPRAZOLE vs RALOXIFENE
RABEPRAZOLE vs RALTEGRAVIR